Propranolol in infantile hemangioma: Indication of major added benefit in some patients
The Institute for Quality and Efficiency in Health Care (IQWiG) investigated in a dossier assessment whether propranolol offers an added benefit in comparison with the appropriate comparator therapy in infants with proliferating ...
Dec 5, 2014
0
0